Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma

Classical MCL (cMCL) constitutes 6–8% of all B cell NHL. Despite recent advances, MCL is incurable except with allogeneic stem cell transplant. Blastic mantle cell lymphoma (bMCL) is a rarer subtype of cMCL associated with an aggressive clinical course and poor treatment response, frequent relapse a...

Descripción completa

Detalles Bibliográficos
Autores principales: LeBlanc, Francis R., Hasanali, Zainul S., Stuart, August, Shimko, Sara, Sharma, Kamal, Leshchenko, Violetta V., Parekh, Samir, Fu, Haiqing, Zhang, Ya, Martin, Melvenia M., Kester, Mark, Fox, Todd, Liao, Jiangang, Loughran, Thomas P., Evans, Juanita, Pu, Jeffrey J., Spurgeon, Stephen E., Aladjem, Mirit I., Epner, Elliot M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450988/
https://www.ncbi.nlm.nih.gov/pubmed/36093297
http://dx.doi.org/10.18632/oncotarget.28258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450988/
https://www.ncbi.nlm.nih.gov/pubmed/36093297
http://dx.doi.org/10.18632/oncotarget.28258

Ejemplares similares